Showing 1–7 of 7 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Gupta M, Ish P, Malhotra N
The recent guidelines on the Programmatic Management of Drug-Resistant Tuberculosis (DR-TB) in India (PMDT) have been released in March 2021 on World TB Day. The new guidelines have considered emerging diagnostic trends including TrueNat, Xpert Mtb/XDR, Next generation sequencing…
Katran ZY, Bulut İ, Babalık A, Keren M, Tepetam FM, et al.
Objective To evaluate drug resıstant tuberculosis patients who developed drug hypersensitivity to antituberculosis drug. Methods This was a retrospective study. The primary aim of the study is to determine the demographic and clinical characteristics of patients who develop drug …
Divya Bhatt, Rashmi Ratnam, Faisal Abbas, Manu Singh, Urmila Singh, et al.
**BACKGROUND:** Ageing affects the clinical presentation of diseases due to associated comorbidities, often leading to diagnostic imprecision and specialized treatment needs in healthcare systems that are not well-equipped to address such challenges. Robust data analysis of geria…
Ghosh A, Biswas VK, Bal HB, Das D, Pati S, et al.
Whole genome sequencing has been used to investigate the genomic diversity of M. tuberculosis in the northern and southern states of India, but information about the eastern part of the country is still limited. Through a sequencing-based strategy, this study seeks to comprehend …
Saeed DK, Shakoor S, Razzak SA, Hasan Z, Sabzwari SF, et al.
…s required so that they may be incorporated in genome-based diagnostics for drug resistant MTB.
Hameed HMA, Tan Y, Islam MM, Guo L, Chhotaray C, et al.
Background Levofloxacin (LVX) and Moxifloxacin (MXF) are the cornerstones for treatment of multidrug-resistant tuberculosis (MDR-TB). China is one of the highest MDR- and fluoroquinolones (FQ)-resistant TB burdens countries. DNA gyrase encoded by gyr genes is the main target of F…
Pinhata JMW, Brandao AP, Gallo JF, Oliveira RS, Ferrazoli L
We assessed the performance of MTBDRsl for detection of resistance to fluoroquinolones, aminoglycosides/cyclic peptides, and ethambutol compared to BACTEC MGIT 960 by subjecting simultaneously to both tests 385 phenotypically multidrug-resistant-Mycobacterium tuberculosis isolate…